784 results on '"Seder, Robert"'
Search Results
2. Variant-proof high affinity ACE2 antagonist limits SARS-CoV-2 replication in upper and lower airways
3. Structural basis for self-discrimination by neoantigen-specific TCRs
4. Author Correction: Intravenous Bacille Calmette–Guérin vaccination protects simian immunodeficiency virus-infected macaques from tuberculosis
5. Intravenous Bacille Calmette–Guérin vaccination protects simian immunodeficiency virus-infected macaques from tuberculosis
6. Natural malaria infection elicits rare but potent neutralizing antibodies to the blood-stage antigen RH5
7. Defining the risk of SARS-CoV-2 variants on immune protection
8. Interaction dynamics between innate and adaptive immune cells responding to SARS-CoV-2 vaccination in non-human primates
9. Structural basis of epitope selectivity and potent protection from malaria by PfCSP antibody L9
10. Mucosal vaccines for SARS-CoV-2: scientific gaps and opportunities—workshop report
11. Systems immunology of transcriptional responses to viral infection identifies conserved antiviral pathways across macaques and humans
12. Cytotoxicity of human antibodies targeting the circumsporozoite protein is amplified by 3D substrate and correlates with protection
13. Blood transcriptional correlates of BCG-induced protection against tuberculosis in rhesus macaques
14. Intravenous heterologous prime-boost vaccination activates innate and adaptive immunity to promote tumor regression
15. Low-dose intravenous and subcutaneous CIS43LS monoclonal antibody for protection against malaria (VRC 612 Part C): a phase 1, adaptive trial
16. Innate immune activation restricts priming and protective efficacy of the radiation-attenuated PfSPZ malaria vaccine
17. Subcutaneous Administration of a Monoclonal Antibody to Prevent Malaria
18. Markov Field network integration of multi-modal data predicts effects of immune system perturbations on intravenous BCG vaccination in macaques
19. Developing tuberculosis vaccines for people with HIV: consensus statements from an international expert panel
20. SARS-CoV-2 Omicron virus causes attenuated disease in mice and hamsters
21. Breadth of SARS-CoV-2 neutralization and protection induced by a nanoparticle vaccine
22. Robust IgM responses following intravenous vaccination with Bacille Calmette–Guérin associate with prevention of Mycobacterium tuberculosis infection in macaques
23. mRNA-1273 protects against SARS-CoV-2 beta infection in nonhuman primates
24. Safety and protective efficacy of PfSPZ Vaccine administered to HIV-negative and -positive Tanzanian adults
25. Adjuvanted SARS-CoV-2 spike protein vaccination elicits long-lived plasma cells in nonhuman primates
26. Vaccine nanodiscs plus polyICLC elicit robust CD8+ T cell responses in mice and non-human primates
27. SARS-CoV-2 variant prediction and antiviral drug design are enabled by RBD in vitro evolution
28. Safety, immunogenicity and efficacy of PfSPZ Vaccine against malaria in infants in western Kenya: a double-blind, randomized, placebo-controlled phase 2 trial
29. Neutralizing antibody vaccine for pandemic and pre-emergent coronaviruses
30. Intravenous nanoparticle vaccination generates stem-like TCF1+ neoantigen-specific CD8+ T cells
31. Antibody-mediated depletion of select T cell subsets in blood and tissue of nonhuman primates
32. Broadly neutralizing antibody induction by non-stabilized SARS-CoV-2 Spike mRNA vaccination in nonhuman primates
33. Durable immunity to SARS-CoV-2 in both lower and upper airways achieved with a gorilla adenovirus (GRAd) S-2P vaccine in non-human primates
34. Mucosal Adenoviral-vectored Vaccine Boosting Durably Prevents XBB.1.16 Infection in Nonhuman Primates
35. 1117 Cellular mechanism of a synthetic star polymer platform for systemic STING agonist cancer immunotherapy
36. Immune Activation Profiles Elicited by Distinct, Repeated TLR Agonist Infusions in Rhesus Macaques
37. Natural malaria infection elicits rare but potent neutralizing antibodies to the blood-stage antigen RH5
38. Peptide–TLR-7/8a conjugate vaccines chemically programmed for nanoparticle self-assembly enhance CD8 T-cell immunity to tumor antigens
39. Vaccine-Induced Linear Epitope-Specific Antibodies to Simian Immunodeficiency Virus SIVmac239 Envelope Are Distinct from Those Induced to the Human Immunodeficiency Virus Type 1 Envelope in Nonhuman Primates
40. Antibody-mediated depletion of select leukocyte subsets in blood and tissue of nonhuman primates.
41. Humoral correlates of protection againstMycobacterium tuberculosisfollowing intravenous Bacille Calmette-Guérin vaccination in rhesus macaques
42. Protective intravenous BCG vaccination induces enhanced immune signaling in the airways
43. Investigation of the impact of clonal hematopoiesis on severity and pathophysiology of COVID-19 in rhesus macaques
44. Bystander responses impact accurate detection of murine and human antigen-specific [CD8.sup.+] T cells
45. Conservation of molecular and cellular phenotypes of invariant NKT cells between humans and non-human primates
46. Malaria prevention: from immunological concepts to effective vaccines and protective antibodies
47. Evaluation of heterologous prime-boost vaccination strategies using chimpanzee adenovirus and modified vaccinia virus for TB subunit vaccination in rhesus macaques
48. Lack of affinity signature for germinal center cells that have initiated plasma cell differentiation
49. HIV Gag Protein Conjugated to a Toll-like Receptor 7/8 Agonist Improves the Magnitude and Quality of Th1 and CD8 + T Cell Responses in Nonhuman Primates
50. Attenuated PfSPZ Vaccine induces strain-transcending T cells and durable protection against heterologous controlled human malaria infection
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.